橫琴誌 | HENGQIN RECORD

Director Luo Wenzhi and President Lu Hong unveiled the plaque for the Liaison Office of the Guangdong Food and Drug Administration in the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao

New Hengqin liaison office to boost communication between medical research groups

The Guangdong Food and Drug Administration has launched a liaison office in Hengqin’s Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong and Macao (GMTCM Park), aiming to provide policy support and guidance for the R&D projects of the park’s enterprises. A Research Centre of Traditional Chinese Medicine Technology and Policy was established on the same day.

According to the organizer, the liaison office will bring together the Guangdong Food and Drug Administration, the GMTCM Park and its enterprises, serving as a communication platform for medical regulatory authorities, industry experts and enterprises in the GMTCM Park and providing medical policy advice and technical guidance to the enterprises during the stages of registration, application and assessment.

Meanwhile, the Research Centre – as a communication platform linking government institutions and enterprises – will arrange regular industry experts, enterprise representatives and government representatives to explore issues related to TCM policy, technology and industry development.

According to President of the Guangdong-Macao Traditional Chinese Medicine Technology Industrial Park Development Co Ltd, Lu Hong, the Park has pushed forward a series of preparations for the technology-based Public Service Platform and the business-based Platform for International Communication and Cooperation. In particular, the Public Service Platform for Good Manufacturing Practice (GMP) pilot scale production that meets the GMP certification standards of both mainland China and the EU, and for R&D and testing, has been completed.

As the first project launched under the “Framework Agreement on Cooperation Between Guangdong and Macao”, GMTCM Park bears the mission of promoting Macau’s economic diversification and the development of the TCM industry, according to the director of Guangdong Food and Drug Administration, Luo Wenzhi.

The Park is the first approved construction project to come from the signing of the “Framework Agreement on Cooperation between Guangdong and Macao” in March 2011 in Beijing. The shareholders of Guangdong-Macau Traditional Chinese Medicine Technology Industrial Park Development Co., Ltd are Macau Investment and Development Limited and Zhuhai Da Hengqin Investment Co., Ltd.

Facebook

Recommended Stories

Latest Stories